Weather Alert: A major winter storm is likely to impact the Philadelphia region this weekend into Monday. Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check Foxchase.org for updates and monitor myTempleHealth for changes to scheduled appointments.
Tumor-Infiltrating Lymphocyte (TIL) Therapy at the Blood Cancer and Cellular Therapy Institute
Personalized Cell-Based Therapy for Patients with Advanced Blood and Solid Tumor Disorders
At the Blood Cancer and Cellular Therapy Institute at Fox Chase Cancer Center, we offer TIL therapy, an advanced form of cellular therapy, for eligible patients with complex hematologic and solid-tumor conditions. This highly individualized treatment harnesses your own immune cells, engineered and expanded, to seek out and destroy disease. Our multidisciplinary team coordinates every step, from eligibility assessment through post-treatment monitoring, ensuring you receive expert care in a program experienced in all hematologic disorders.
- Specialized cellular therapy and hematology/oncology teams with deep experience in cellular therapies for both hematologic and solid tumors.
- State-of-the-art infrastructure dedicated to immune-based therapies and transplant-level care
- Access to clinical trials and novel treatments, giving you more options when traditional therapies are not sufficient
Special Treatments & Technologies:
- TIL Therapy – Your own lymphocytes are harvested from a tumor sample, expanded into the billions in a lab, and then re-infused to fight disease. We support all phases — eligibility, manufacturing, infusion, and follow-up. Philadelphia Magazine
- CAR T-Cell & Bispecific Antibody Therapies – For patients with blood cancers or disorders, we also offer next-generation immune-cell treatments alongside TIL for a comprehensive cellular therapy portfolio.
- Integrated Cellular Therapy & Transplant Care – Patients receive treatment in our transplant-level facility with experienced teams, HEPA-filtered rooms, and close monitoring throughout the critical early period.
Request an appointment online or call 866-385-0234. For general information, visit our Contact Us page.
